<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <relatedBills>
      <item>
        <type>HR</type>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
        <congress>113</congress>
        <latestTitle>Cancer Drug Coverage Parity Act of 2013</latestTitle>
        <number>1801</number>
        <latestAction>
          <text>Referred to the Subcommittee on Health, Employment, Labor, and Pensions.</text>
          <actionDate>2013-07-08</actionDate>
        </latestAction>
      </item>
    </relatedBills>
    <updateDate>2016-10-25T16:28:17Z</updateDate>
    <committees>
      <billCommittees>
        <item>
          <type>Standing</type>
          <subcommittees />
          <name>Health, Education, Labor, and Pensions Committee</name>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2013-12-20T00:41:16Z</date>
            </item>
          </activities>
          <systemCode>sshr00</systemCode>
          <chamber>Senate</chamber>
        </item>
      </billCommittees>
    </committees>
    <sponsors>
      <item>
        <fullName>Sen. Franken, Al [D-MN]</fullName>
        <middleName />
        <bioguideId>F000457</bioguideId>
        <identifiers>
          <lisID>1969</lisID>
          <gpoId>8339</gpoId>
          <bioguideId>F000457</bioguideId>
        </identifiers>
        <byRequestType />
        <lastName>Franken</lastName>
        <party>D</party>
        <state>MN</state>
        <firstName>Al</firstName>
      </item>
    </sponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <latestAction>
      <links />
      <actionDate>2013-12-19</actionDate>
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </latestAction>
    <originChamber>Senate</originChamber>
    <cosponsors>
      <item>
        <party>R</party>
        <middleName>STEVEN</middleName>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
        <bioguideId>K000360</bioguideId>
        <firstName>MARK</firstName>
        <identifiers>
          <lisID>1647</lisID>
          <bioguideId>K000360</bioguideId>
          <gpoId>8285</gpoId>
        </identifiers>
        <state>IL</state>
        <sponsorshipDate>2013-12-19</sponsorshipDate>
        <fullName>Sen. Kirk, Mark Steven [R-IL]</fullName>
        <lastName>KIRK</lastName>
      </item>
    </cosponsors>
    <billNumber>1879</billNumber>
    <titles>
      <item>
        <chamberCode />
        <parentTitleType />
        <chamberName />
        <titleType>Short Titles as Introduced</titleType>
        <title>Cancer Treatment Parity Act of 2013</title>
      </item>
      <item>
        <chamberCode />
        <parentTitleType />
        <chamberName />
        <titleType>Official Title as Introduced</titleType>
        <title>A bill to amend the Employee Retirement Income Security Act of 1974, the Public Health Service Act, and the Internal Revenue Code of 1986 to require group and individual health insurance coverage and group health plans to provide for coverage of oral anticancer drugs on terms no less favorable than the coverage provided for anticancer medications administered by a health care provider.</title>
      </item>
      <item>
        <chamberCode />
        <parentTitleType />
        <chamberName />
        <titleType>Display Title</titleType>
        <title>Cancer Treatment Parity Act of 2013</title>
      </item>
    </titles>
    <createDate>2013-12-20T07:01:25Z</createDate>
    <notes />
    <title>Cancer Treatment Parity Act of 2013</title>
    <calendarNumbers />
    <congress>113</congress>
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Cancer</name>
          </item>
          <item>
            <name>Congressional oversight</name>
          </item>
          <item>
            <name>Drug therapy</name>
          </item>
          <item>
            <name>Employee benefits and pensions</name>
          </item>
          <item>
            <name>Government studies and investigations</name>
          </item>
          <item>
            <name>Health care costs and insurance</name>
          </item>
          <item>
            <name>Health care coverage and access</name>
          </item>
          <item>
            <name>Medicare</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
    <cboCostEstimates />
    <summaries>
      <billSummaries>
        <item>
          <name>Introduced in Senate</name>
          <actionDesc>Introduced in Senate</actionDesc>
          <lastSummaryUpdateDate>2013-12-31T19:58:55Z</lastSummaryUpdateDate>
          <actionDate>2013-12-19</actionDate>
          <text><![CDATA[<p>Cancer Treatment Parity Act of 2013 - Amends the Employee Retirement Income Security Act of 1974 (ERISA), the Public Health Service Act, and the Internal Revenue Code to require a group or individual health plan providing benefits with respect to anticancer medications administered by a health care provider to provide no less favorable coverage for prescribed, patient-administered anticancer medications used to kill, slow, or prevent the growth of cancerous cells and that have been approved by the Food and Drug Administration (FDA).</p> <p>Applies such requirement to medication that is prescribed based on a finding by the treating physician that the medication is: (1) medically necessary for the purpose of killing, slowing, or preventing the growth of cancerous cells in accordance with nationally accepted standards of medical practice; and (2) clinically appropriate in terms of type, frequency, extent site, and duration.</p> <p>Permits such coverage to be subject to the same cost-sharing applicable to anticancer medications administered by a health care provider under the plan.</p> <p> Prohibits a health plan from imposing an increase in out-of-pocket costs, reclassifying benefits with respect to anticancer medications, or applying more restrictive limitations on prescribed orally- or intravenously-administered or injected anticancer medications.</p> <p>Requires a plan to provide notice to each participant and beneficiary regarding the coverage required under this Act.</p> <p>Requires the Medicare Payment Advisory Commission to assess how closing the Medicare part D donut hole affects Medicare coverage for orally-administered anticancer medications, with a particular focus on cost and accessibility.</p>]]></text>
          <versionCode>00</versionCode>
          <updateDate>2013-12-19T05:00:00Z</updateDate>
        </item>
      </billSummaries>
    </summaries>
    <introducedDate>2013-12-19</introducedDate>
    <amendments />
    <laws />
    <committeeReports />
    <actions>
      <actionTypeCounts>
        <introducedInSenate>1</introducedInSenate>
        <referredToCommittee>1</referredToCommittee>
      </actionTypeCounts>
      <item>
        <actionDate>2013-12-19</actionDate>
        <committee>
          <name>Health, Education, Labor, and Pensions Committee</name>
          <systemCode>sshr00</systemCode>
        </committee>
        <links />
        <sourceSystem>
          <name>Senate</name>
          <code>0</code>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionCode>10000</actionCode>
        <actionDate>2013-12-19</actionDate>
        <type>IntroReferral</type>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <links />
        <text>Introduced in Senate</text>
        <committee />
      </item>
      <actionByCounts>
        <senate>2</senate>
      </actionByCounts>
    </actions>
    <billType>S</billType>
    <recordedVotes />
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

